Related Experiment Video
Updated: Apr 17, 2026

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
From crystal structure to in silico epitope discovery in the Burkholderia pseudomallei flagellar hook-associated
Louise J Gourlay1, Rachael J Thomas, Claudio Peri
1Department of Biosciences, University of Milan, Italy.
Abstract:
Melioidosis, caused by the Gram-negative bacterium Burkholderia pseudomallei, is a potentially fatal infection that is endemic in Southeast Asia and Northern Australia that is poorly controlled by antibiotics. Research efforts to identify antigenic components for a melioidosis vaccine have led to the identification of several proteins, including subunits forming the flagella that mediate bacterial motility, host colonization, and virulence. This study focuses on the B. pseudomallei flagellar hook-associated protein (FlgK(Bp)), and provides the first insights into the 3D structure of FlgK proteins as targets for structure-based antigen engineering. The FlgK(Bp) crystal structure (presented here at 1.8-Å resolution) reveals a multidomain fold, comprising two small β-domains protruding from a large elongated α-helical bundle core. The evident structural similarity to flagellin, the flagellar filament subunit protein, suggests that, depending on the bacterial species, flagellar hook-associated proteins are likely to show a conserved, elongated α-helical bundle scaffold coupled to a variable number of smaller domains. Furthermore, we present immune serum recognition data confirming, in agreement with previous findings, that recovered melioidosis patients produce elevated levels of antibodies against FlgK(Bp), in comparison with seronegative and seropositive healthy subjects. Moreover, we show that FlgK(Bp) has cytotoxic effects on cultured murine macrophages, suggesting an important role in bacterial pathogenesis. Finally, computational epitope prediction methods applied to the FlgK(Bp) crystal structure, coupled with in vitro mapping, allowed us to predict three antigenic regions that locate to discrete protein domains. Taken together, our results point to FlgK(Bp) as a candidate for the design and production of epitope-containing subunits/domains as potential vaccine components.
Insights
This study reveals the 3D structure of Burkholderia pseudomallei flagellar hook-associated protein (FlgK(Bp)), identifying key antigenic regions. These findings suggest FlgK(Bp) is a promising candidate for developing a melioidosis vaccine.
Area of Science:
- Structural biology
- Bacteriology
- Immunology
Background:
- Melioidosis, caused by Burkholderia pseudomallei, is a severe infection prevalent in Southeast Asia and Australia, inadequately treated by antibiotics.
- Flagellar proteins, including FlgK(Bp), are crucial for bacterial motility, host colonization, and virulence, making them targets for vaccine development.
Purpose of the Study:
- To elucidate the 3D structure of B. pseudomallei FlgK(Bp) for structure-based antigen engineering.
- To investigate the antigenic properties and pathogenic role of FlgK(Bp) for potential vaccine design.
Main Methods:
- X-ray crystallography to determine the 1.8-Å resolution structure of FlgK(Bp).
- Analysis of immune serum from melioidosis patients and healthy subjects.
- Assessment of FlgK(Bp) cytotoxicity on murine macrophages.
- Computational epitope prediction and in vitro mapping.
Main Results:
- The FlgK(Bp) structure reveals a multidomain fold with an elongated α-helical bundle core, similar to flagellin.
- Recovered melioidosis patients exhibit higher antibody levels against FlgK(Bp).
- FlgK(Bp) demonstrates cytotoxic effects on macrophages, indicating a role in pathogenesis.
- Three distinct antigenic regions on FlgK(Bp) were identified through computational and experimental methods.
Conclusions:
- FlgK(Bp) possesses a conserved structural scaffold with potential antigenic sites.
- FlgK(Bp) contributes to B. pseudomallei pathogenesis and elicits an immune response in infected individuals.
- FlgK(Bp) is a viable candidate for developing subunit-based melioidosis vaccines targeting specific epitopes.

